Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
Biostrata Ltd on behalf of Thermo
RANDOX LABORATORIES

Collection Device for Sputum Introduced

By Labmedica International staff writers
Posted on 30 Jan 2012
Image: Whole Saliva Collection Device (Photo courtesy of SalivaBio LLC).
Image: Whole Saliva Collection Device (Photo courtesy of SalivaBio LLC).
A new tool has been introduced that makes collecting oral fluids more accurate and much easier.

The collection tube apparatus will enable saliva analytes to be integrated effectively into the clinical laboratory testing process, precisely and hygienically.

The tool, which was developed by the Johns Hopkins University School of Nursing Center for Interdisciplinary Salivary Bioscience Research (CISBR; Baltimore MD, USA), will improve the ease of oral fluid collection, while maintaining the integrity of the biospecimen.

The new Whole Saliva Collection Device is a small, polypropylene collection tube with an integral adapter that comes individually wrapped in a clean, foil pouch with ready-to-go instructions, and is a universal fit with common cryogenic vials. The planned availability for the device is February 2012. Saliva is full of analytes and biomarkers that create a biological journal of exposure to chemicals and disease, and genetic variability. However, the collection of oral fluid has always proved cumbersome, with scientists depending on swabs or collection cups.

Whole saliva is the gold standard when collecting oral fluid for biological testing. Its collection avoids the localized secretions of specific salivary glands making it a more consistent specimen. Whole Saliva can be easily evaluated for volume collected and for salivary flow rate. Free from being compromised by absorbing materials used with other collection methods, Whole Saliva can be assayed for any salivary analyte of interest.

Douglas A. Granger, PhD, director of CISBR and professor of Medicine, Nursing, and Public Health at Johns Hopkins is cofounder of the newly formed commercial company SalivaBio, LLC (Baltimore, MD, USA). Prof. Granger said, "Our studies show that swabs used to collect saliva can retain analytes, cause interference with assays, result in inaccurate estimates of saliva flow rates, and may even produce inaccurate assay results. It's not rocket science; it's a practical solution that will enable saliva analytes to be integrated effectively into basic and clinical studies and consumer applications."

Related Links:

Johns Hopkins University School of Nursing Center
SalivaBio, LLC



KARL HECHT GMBH & CO KG
EUROIMMUN AG
CELLAVISION AB
WATERS CORPORATION

Channels

Clinical Chemistry

view channel
Image: The Avance III 600 spectrometer for proton nuclear magnetic resonance analysis (Photo courtesy of Bruker).

New Blood Test Can Predict Future Breast Cancer

The analysis of a blood sample could predict if a woman will get breast cancer within two to five years which could create a paradigm shift in early diagnosis of this malignant neoplasm as well as other diseases.... Read more

Genetic Tests

view channel

Buccal Swabs Replace Phlebotomy for Postnatal and Pediatric DNA Collection

Collection of samples for prenatal and pediatric DNA sequencing procedures is now available via buccal swabs rather than by phlebotomy. CombiMatrix Corporation (Irvine, CA, USA) a molecular diagnostics company specializing in DNA-based diagnostic services for prenatal, postnatal, and pre-implantation genetic testing... Read more

Hematology

view channel
Image: The new point-of-care Hemo Control delivers laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely offers flexible and enhanced data management with bi-directional interface (Photo courtesy of EKF Diagnostics).

Next-Generation Hemoglobin Analyzer Uniquely Ensures Bi-Directional Data Management Future Proofing

A new point-of-care (POC) diagnostics analyzer delivers quantitative laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely enables upgrade with data management functionality... Read more

Industry News

view channel

Main Factors Driving Revenue Growth in Clinical Chemistry Identified

According to a report by Kalorama Information (New York, NY, USA), overall growth in the clinical chemistry market will be modest, driven mainly by new tests and demographic changes, including an aging population and increasing number of people at risk of cardiovascular disease, such as those with hypertension, diabetes... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.